Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sable Offshore | SOC | Mar 28, 2024 | 10.96 | 0.00 |
Sabra Health Care REIT | SBRA | Mar 28, 2024 | 14.77 | +1.30 |
Sabre | SABR | Mar 28, 2024 | 2.42 | +0.41 |
Sachem Capital | SACH | Mar 28, 2024 | 4.46 | 0.00 |
Sachem Capital A Pref | SACH-A | Mar 28, 2024 | 24.01 | +0.04 |
Sacks Parente Golf | SPGC | Mar 28, 2024 | 0.60 | +2.56 |
Sadot Group | SDOT | Mar 28, 2024 | 0.30 | +0.34 |
Safe And Green Development | SGD | Mar 28, 2024 | 0.84 | -4.55 |
Safe Bulkers | SB | Mar 28, 2024 | 4.96 | 0.00 |
Safe Bulkers Pref C | SB-C | Mar 28, 2024 | 25.87 | +0.47 |
Safe Bulkers Pref D | SB-D | Mar 28, 2024 | 26.22 | -0.30 |
Safehold | SAFE | Mar 28, 2024 | 20.60 | +2.08 |
Safety Insurance Group | SAFT | Mar 28, 2024 | 82.19 | +0.51 |
Safety Shot | SHOT | Mar 28, 2024 | 2.39 | +0.84 |
Saga Communications A | SGA | Mar 28, 2024 | 22.31 | -0.22 |
Sagaliam Acquisition A | SAGA | Mar 28, 2024 | 10.88 | 0.00 |
Sage Therapeutics | SAGE | Mar 28, 2024 | 18.74 | -1.58 |
Sagimet Biosciences | SGMT | Mar 28, 2024 | 5.42 | -5.41 |
SAI.TECH Global | SAI | Mar 28, 2024 | 1.16 | +9.43 |
Saia | SAIA | Mar 28, 2024 | 585.00 | +0.78 |
Salarius Pharmaceuticals | SLRX | Mar 28, 2024 | 0.53 | +8.99 |
Salesforce | CRM | Mar 28, 2024 | 301.18 | -0.07 |
Sally Beauty | SBH | Mar 28, 2024 | 12.42 | +2.05 |
San Juan Basin Royalty Trust Unit | SJT | Mar 28, 2024 | 5.29 | -0.19 |
Sana Biotechnology | SANA | Mar 28, 2024 | 10.00 | 0.00 |
Sanara MedTech | SMTI | Mar 28, 2024 | 37.00 | -0.80 |
SandRidge Energy | SD | Mar 28, 2024 | 14.57 | +0.41 |
Sandstorm Gold | SAND | Mar 28, 2024 | 5.25 | +2.14 |
Sandy Spring Bancorp | SASR | Mar 28, 2024 | 23.18 | +1.98 |
Sangamo Therapeutics | SGMO | Mar 28, 2024 | 0.67 | +7.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.